A Curated Platform of Equity & Options Market Intelligence
Select Page

ESPR

Search by
TICKER SYMBOL

Esperion Therapeutics Inc.

Sector:
Industry:

2.14

-0.17

(-7.359%)

Volume:

0

52 week range:

0.7 - 3.4

Market Cap:

405.317M

Company Description:

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an inhibitor of atp citrate lyase, a well-characterized enzyme on the cholesterol biosynthesis pathway; the same pathway that includes hmg-coa reductase, the enzyme target of statins. the company has successfully completed its phase 1 and phase 2 development programs for etc-1002, and plans to initiate its etc-1002 phase 3 development program by the end of 2015. for more information, please visit www.esperion.com.